TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Details
01. General Information
Name Immune checkpoint blockers
Drug Type Not Available
Toxicity Organism Test Type Route(Dose)
Structure 2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Enhancing Drug Efficacy
Hide/Show
Combination Pair ID: 796
Pair Name Withaferin A, Immune checkpoint blockers
Partner Name Withaferin A
Disease Info [ICD-11: 2C25.Z] Lung cancer Investigative
Biological Phenomena Induction-->Immunomodulatory
Gene Regulation Up-regulation Expression CD274 hsa29126
In Vivo Model To establish the LLC syngeneic tumors, C57BL/6 mice were injected with a half million cells on the right flank and monitored until tumors were first palpable (2–3 mm diameter).
Result Our results demonstrate that WFA sensitizes NSCLC to α-PD-L1 in part via activation of ROS.
03. Reference
No. Title Href
1 Withaferin A Increases the Effectiveness of Immune Checkpoint Blocker for the Treatment of Non-Small Cell Lung Cancer. Cancers (Basel). 2023 Jun 7;15(12):3089. doi: 10.3390/cancers15123089. Click
It has been 248061 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP